Picard Medical, Inc.
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| – | -26.3% | +6.4% | +86.3% | |
| – | -27.7% | +11.8% | +111.7% | |
| – | +60.5% | -60.7% | +7,661.5% | |
| – | +60.5% | -60.7% | +7,661.5% | |
| – | -79.7% | -15.7% | +21.1% | |
| – | -5.9% | +17.7% | -10.0% | |
| – | -32.0% | -16.0% | – | |
| – | +0.0% | +0.0% | +0.0% | |
| – | -11.3% | -12.9% | -14.6% | |
| – | +266.6% | +140.1% | -47.7% | |
| – | +207.2% | +283.5% | -47.1% | |
| – | +392.3% | +367.4% | -66.1% | |
| – | +121.5% | +71.7% | -60.7% | |
| – | – | -100.0% | – | |
| – | -131.2% | – | – | |
| – | – | – | – | |
| – | +0.0% | +0.0% | +2.3% |
Data as of: September 28, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.